Company Filing History:
1 out of 5 Years Active: 2024-2025
Title: Innovations of Jinhua Huang
Introduction
Jinhua Huang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of T cell receptors and therapeutic agents. With a total of 2 patents, Huang's work is paving the way for advancements in cancer treatment.
Latest Patents
Huang's latest patents include a high-affinity T cell receptor (TCR) designed for targeting tumor cells presenting the SLLMWITQC-HLA A2 complex. This innovative TCR exhibits a binding affinity that is at least twice that of a wild-type TCR, enhancing its potential effectiveness in therapeutic applications. Additionally, he has developed a fusion molecule that combines this TCR with a therapeutic agent, allowing for more targeted treatment options.
Career Highlights
Jinhua Huang is currently associated with Xlifesc, Ltd., where he continues to push the boundaries of medical technology. His work focuses on creating solutions that can significantly improve patient outcomes in oncology.
Collaborations
Huang collaborates with talented individuals in his field, including Yi Li, who contributes to the innovative projects at Xlifesc, Ltd. Their teamwork exemplifies the collaborative spirit necessary for groundbreaking advancements in biotechnology.
Conclusion
Jinhua Huang's contributions to the field of biotechnology through his patents and collaborative efforts highlight his role as a key innovator. His work not only advances scientific knowledge but also holds promise for future medical applications.